PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 17, 2025Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition0 citations

A quantitative MRI-Based Normative Framework for Personalizing Microstructural Pathology in Multiple Sclerosis

View Full Paper
XCXinjie ChenPLPo‐Jui LuMOMario Ocampo‐Pineda

Key Points

  • Significant differences were observed in cortical microstructures among MS phenotypes, correlating with clinical measures.
  • The study utilized quantitative MRI data with hierarchical Bayesian regression to assess microstructural changes.
  • Normative models based on qMRI facilitate individualized quantification of MS pathology linked to biomarkers of neuro-axonal damage.
  • This approach opens new avenues for clinical stratification and personalized treatment decisions in MS management.

Abstract

Motivation: Quantitative MRI (qMRI) offers a unique perspective for investigating microstructural pathological changes in multiple sclerosis (MS). This study employs qMRI-based normative modeling for tracking individual MS pathology. Goal(s): To quantify personalized cortical microstructural changes in patients with MS using qMRI-based normative models. Approach: Hierarchical Bayesian Regression-based normative models were developed using quantitative multiparametric (R1, R2*, Quantitative Susceptibility Mapping) data across two centers to quantify regional cortical microstructural changes in people with MS. Results: qMRI-based deviations in cortical microstructure exhibited significant differences across various phenotypes and correlated with clinical measures of MS disability and biofluid measures of neuro-axonal damage. Impact: This qMRI-based normative model enables individualized quantification of multiple sclerosis pathology, which is strongly related to clinical measures and a fluid biomarker of neuroaxonal damage, opening a new perspective for clinical stratification and personalized treatment decisions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chen et al. (2025) studied this question.

synapsesocial.com/papers/68d4597b31b076d99fa5cd14https://doi.org/10.58530/2025/3754
Ask AI
Helpful
Bookmark
Share
View Full Paper